Eradication of an outbreak of vancomycin-resistant Enterococcus (VRE): the cost of a failure in the systematic screening

被引:0
作者
Lélia Escaut
Samir Bouam
Marie Frank-Soltysiak
Eric Rudant
Faouzi Saliba
Najiby Kassis
Paul Presiozi
Daniel Vittecoq
机构
[1] Bicêtre Hospital,Department of infectious and tropical diseases
[2] Unité de Maladies Infectieuses et Tropicales,Department of hospital information
[3] Hôpital Paul Brousse,Department of public health
[4] Paul Brousse Hospital,Laboratory of pharmacy
[5] Bicêtre Hospital,Hepatobiliary centre
[6] Paul Brousse Hospital,Laboratory of microbiology
[7] Paul Brousse Hospital,undefined
[8] Paul Brousse Hospital,undefined
[9] ClinSearch,undefined
来源
Antimicrobial Resistance and Infection Control | / 2卷
关键词
Active surveillance; Outbreak; Cost; Vancomycin-resistant ;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Evaluation of Vancomycin-Resistant Enterococci (VRE)-Associated Morbidity Following Relaxation of VRE Screening and Isolation Precautions in a Tertiary Care Hospital
    Popiel, Kristin Y.
    Miller, Mark A.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2014, 35 (07) : 818 - 825
  • [22] First outbreak of linezolid-resistant vancomycin-resistant Enterococcus faecium in an Irish hospital, February to September 2014
    O'Driscoll, C.
    Murphy, V.
    Doyle, O.
    Wrenn, C.
    Flynn, A.
    O'Flaherty, N.
    Fenelon, L. E.
    Schaffer, K.
    FitzGerald, S. F.
    JOURNAL OF HOSPITAL INFECTION, 2015, 91 (04) : 367 - 370
  • [23] Laboratory Antimicrobial Stewardship During an Outbreak of Linezolid- and Vancomycin-resistant Enterococcus faecium Bacteremia
    Schuetz, Audrey N.
    CLINICAL INFECTIOUS DISEASES, 2019, 69 (02) : 266 - 267
  • [24] Advances in prevention and treatment of vancomycin-resistant Enterococcus infection
    Isenman, Heather
    Fisher, Dale
    CURRENT OPINION IN INFECTIOUS DISEASES, 2016, 29 (06) : 577 - 582
  • [25] Increased Risk of Vancomycin-resistant Enterococcus (VRE) Infection Among Patients Hospitalized for Inflammatory Bowel Disease in the United States
    Nguyen, Geoffrey C.
    Leung, Wesley
    Weizman, Adam V.
    INFLAMMATORY BOWEL DISEASES, 2011, 17 (06) : 1338 - 1342
  • [26] Interhospital transmission of vancomycin-resistant Enterococcus faecium in Aomori, Japan
    Saito, Norihiro
    Kitazawa, Junichi
    Horiuchi, Hiroko
    Yamamoto, Takeo
    Kimura, Masahiko
    Inoue, Fumio
    Matsui, Mika
    Minakawa, Satoko
    Itoga, Masamichi
    Tsuchiya, Junichiro
    Suzuki, Satowa
    Hisatsune, Junzo
    Gu, Yoshiaki
    Sugai, Motoyuki
    Kayaba, Hiroyuki
    ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2022, 11 (01)
  • [27] Vancomycin-Resistant Enterococcus faecium in Tunisia: Emergence of Novel Clones
    Dziri, Raoudha
    El Kara, Feriel
    Barguellil, Farouk
    Ouzari, Hadda-Imen
    El Asli, Mohamed Selim
    Klibi, Naouel
    MICROBIAL DRUG RESISTANCE, 2019, 25 (04) : 469 - 474
  • [28] High frequency and diversity of Vancomycin-resistant Enterococci (VRE) in Algerian healthcare settings
    Zerrouki, Hanane
    Rebiahi, Sid-Ahmed
    Hadjadj, Linda
    Ahlem, Fatmi
    Elhabiri, Yamina
    Sedrati, Tahar
    Rolain, Jean-Marc
    Diene, Seydina M.
    INFECTION GENETICS AND EVOLUTION, 2021, 92
  • [29] PHENOTYPIC FREQENCY OF VANCOMYCIN-RESISTANT ENTEROCOCCI (VRE) IN TEHRAN'S CLINICAL SPECIMENS
    Zavaryani, Sara Masoumi
    Mirnejad, Reza
    Karizi, ShohrehZare
    Rahbar, Mohammad
    ImaniFooladi, Abbasali
    Saeidi, Somayyeh
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2016, 45 : 77 - 77
  • [30] Investigation of a vanA linezolid- and vancomycin-resistant Enterococcus faecium outbreak in the Southwest Indian Ocean (Reunion Island)
    Kamus, Laure
    Auger, Gabriel
    Gambarotto, Karine
    Houivet, Julien
    Ramiandrisoa, Mahery
    Picot, Sandrine
    Lugagne-Delpon, Nathalie
    Jaffar-Bandjee, Marie -Christine
    Zouari, Asma
    Birer, Aurelien
    Nogues, Sophie
    Collet, Anais
    Lecourt, Maxime
    Belmonte, Olivier
    Cattoir, Vincent
    Miltgen, Guillaume
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2022, 60 (5-6)